NO974486L - Lavdoserte "Ridogrel"-formuleringer samt anvendelse derav ved behandling av tarmbetennelse - Google Patents
Lavdoserte "Ridogrel"-formuleringer samt anvendelse derav ved behandling av tarmbetennelseInfo
- Publication number
- NO974486L NO974486L NO974486A NO974486A NO974486L NO 974486 L NO974486 L NO 974486L NO 974486 A NO974486 A NO 974486A NO 974486 A NO974486 A NO 974486A NO 974486 L NO974486 L NO 974486L
- Authority
- NO
- Norway
- Prior art keywords
- ridogrel
- treatment
- dose
- formulations
- low
- Prior art date
Links
- GLLPUTYLZIKEGF-HAVVHWLPSA-N ridogrel Chemical compound C=1C=CC(C(F)(F)F)=CC=1C(=N/OCCCCC(=O)O)\C1=CC=CN=C1 GLLPUTYLZIKEGF-HAVVHWLPSA-N 0.000 title abstract 4
- 229950006674 ridogrel Drugs 0.000 title abstract 4
- 206010061218 Inflammation Diseases 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 230000000968 intestinal effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000037396 body weight Effects 0.000 abstract 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det er beskrevet anvendelse av "Ridogrel" ved frem- stilling av et medikament egnet for behandling av inflammatoriske tarmsykdommer hvor "Ridogrel" til- føres i en daglig dose fra 0,01 mg per kg kropps- vekt til 0,5 mg per kg kroppsvekt, samt farmaszy- tiske sammensetninger omfattende "Ridogrel".
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95200768 | 1995-03-28 | ||
| PCT/EP1996/001229 WO1996030016A2 (en) | 1995-03-28 | 1996-03-18 | Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO974486D0 NO974486D0 (no) | 1997-09-29 |
| NO974486L true NO974486L (no) | 1997-09-29 |
Family
ID=8220134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO974486A NO974486L (no) | 1995-03-28 | 1997-09-29 | Lavdoserte "Ridogrel"-formuleringer samt anvendelse derav ved behandling av tarmbetennelse |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0817631A2 (no) |
| JP (1) | JPH10511097A (no) |
| AR (1) | AR002727A1 (no) |
| AU (1) | AU5397496A (no) |
| CA (1) | CA2215160A1 (no) |
| HU (1) | HUP9900309A3 (no) |
| IL (1) | IL117670A (no) |
| NO (1) | NO974486L (no) |
| WO (1) | WO1996030016A2 (no) |
| ZA (1) | ZA962461B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9620709D0 (en) * | 1996-10-04 | 1996-11-20 | Danbiosyst Uk | Colonic delivery of weak acid drugs |
| WO2002072069A1 (en) * | 2001-03-12 | 2002-09-19 | Novo Nordisk A/S | Novel tablets and capsules and a process for its preparation |
| ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| HRP20170936T1 (hr) | 2009-02-16 | 2017-09-22 | Nogra Pharma Limited | Alkilamido spojevi i njihova uporaba |
| WO2013117744A2 (en) | 2012-02-09 | 2013-08-15 | Nogra Pharma Limited | Methods of treating fibrosis |
| NZ631049A (en) | 2012-04-18 | 2017-02-24 | Nogra Pharma Ltd | Methods of treating lactose intolerance |
| WO2017046343A1 (en) * | 2015-09-17 | 2017-03-23 | Nogra Pharma Limited | Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same |
| AU2020217884B2 (en) | 2019-02-08 | 2025-02-20 | Nogra Pharma Limited | Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4746671A (en) * | 1985-11-04 | 1988-05-24 | Janssen Pharmaceutica N.V. | Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters |
-
1996
- 1996-03-18 JP JP8528894A patent/JPH10511097A/ja active Pending
- 1996-03-18 EP EP96910921A patent/EP0817631A2/en not_active Withdrawn
- 1996-03-18 WO PCT/EP1996/001229 patent/WO1996030016A2/en not_active Ceased
- 1996-03-18 CA CA002215160A patent/CA2215160A1/en not_active Abandoned
- 1996-03-18 AU AU53974/96A patent/AU5397496A/en not_active Abandoned
- 1996-03-18 HU HU9900309A patent/HUP9900309A3/hu unknown
- 1996-03-27 IL IL11767096A patent/IL117670A/xx active IP Right Grant
- 1996-03-27 ZA ZA9602461A patent/ZA962461B/xx unknown
- 1996-03-27 AR ARP960101944A patent/AR002727A1/es unknown
-
1997
- 1997-09-29 NO NO974486A patent/NO974486L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996030016A2 (en) | 1996-10-03 |
| IL117670A0 (en) | 1996-07-23 |
| AR002727A1 (es) | 1998-04-29 |
| NO974486D0 (no) | 1997-09-29 |
| WO1996030016A3 (en) | 1997-01-30 |
| AU5397496A (en) | 1996-10-16 |
| CA2215160A1 (en) | 1996-10-03 |
| HUP9900309A2 (hu) | 1999-05-28 |
| HUP9900309A3 (en) | 1999-11-29 |
| JPH10511097A (ja) | 1998-10-27 |
| EP0817631A2 (en) | 1998-01-14 |
| IL117670A (en) | 2000-02-29 |
| ZA962461B (en) | 1997-09-29 |
| MX9707394A (es) | 1997-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY125662A (en) | Pharmaceutical formulations containing darifenacin | |
| BRPI0015284B8 (pt) | formulações de hidrocodona de liberação controlada | |
| CA2227887A1 (en) | Pharmaceutical compositions of conjugated estrogens and methods for their use | |
| EP0254067A3 (en) | Composition for metastasis prevention | |
| KR970061244A (ko) | 치매 치료용 약학 조성물 | |
| CA2038744A1 (en) | Pharmaceutical composition containing slightly water-soluble drug | |
| HUP9801241A2 (hu) | Vastagbélbe beadható, azathioprine tartalmú készítmények és eljárás előállításukra | |
| NO974486L (no) | Lavdoserte "Ridogrel"-formuleringer samt anvendelse derav ved behandling av tarmbetennelse | |
| ATE254463T1 (de) | Verwendung von valaciclovir zur herstellung eines arzneimittels zur behandlung von genitalherpes durch einmal tägliche verabreichung | |
| IL135235A0 (en) | Method and composition for preventing nephrotoxicity caused by cyclosporins and tacrolimus | |
| CA2180178A1 (en) | Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis | |
| JP2000512270A (ja) | 単純ヘルペスの処置のための組成物および方法 | |
| WO1993017691A3 (en) | Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease | |
| ATE91890T1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
| AU640207B2 (en) | Process and composition for the treating of injuries caused by the radiation of heat and light | |
| RU99112967A (ru) | Способ лечения и профилактики дизентерии свиней | |
| US4156003A (en) | Treatment of hypertension with combination of clofibrinic acid or clofibrate with cinnarizine | |
| IT8247658A1 (it) | Medicamenti a base di derivati condensati dell'imidazolo per il trattamento di disturbi urinari | |
| KR830008678A (ko) | 진통 조성물 | |
| WO1999029330A8 (en) | Composition and method for treating nonalcoholic steatohepatitis | |
| RU2121347C1 (ru) | Лекарственный препарат | |
| EP0230125A1 (en) | Admixtures of diflunisal and tromethamine | |
| TH25792A (th) | สูตรผสมริโดเจรลขนาดต่ำ | |
| CA1261269A (en) | Herpes simplex treatment | |
| Guibert | Acute cystitis in women: Effectiveness of ciprofloxacin versus pefloxacin given as a single oral dose. |